↓ Skip to main content

Polyglutamine Disorders

Overview of attention for book
Cover of 'Polyglutamine Disorders'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Clinical Features of Huntington’s Disease
  3. Altmetric Badge
    Chapter 2 Genetic Rodent Models of Huntington Disease
  4. Altmetric Badge
    Chapter 3 Mitochondrial Dysfunction in Huntington’s Disease
  5. Altmetric Badge
    Chapter 4 RNA Related Pathology in Huntington’s Disease
  6. Altmetric Badge
    Chapter 5 X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity
  7. Altmetric Badge
    Chapter 6 Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies
  8. Altmetric Badge
    Chapter 7 Spinocerebellum Ataxia Type 6: Molecular Mechanisms and Calcium Channel Genetics
  9. Altmetric Badge
    Chapter 8 Spinocerebellar Ataxia Type 2
  10. Altmetric Badge
    Chapter 9 Molecular Mechanisms and Therapeutic Strategies in Spinocerebellar Ataxia Type 7
  11. Altmetric Badge
    Chapter 10 Spinocerebellar Ataxia Type 17 (SCA17)
  12. Altmetric Badge
    Chapter 11 The Neuropathology of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
  13. Altmetric Badge
    Chapter 12 Origins and Spread of Machado-Joseph Disease Ancestral Mutations Events
  14. Altmetric Badge
    Chapter 13 Clinical Features of Machado-Joseph Disease
  15. Altmetric Badge
    Chapter 14 Polyglutamine-Independent Features in Ataxin-3 Aggregation and Pathogenesis of Machado-Joseph Disease
  16. Altmetric Badge
    Chapter 15 Animal Models of Machado-Joseph Disease
  17. Altmetric Badge
    Chapter 16 Towards the Identification of Molecular Biomarkers of Spinocerebellar Ataxia Type 3 (SCA3)/Machado-Joseph Disease (MJD)
  18. Altmetric Badge
    Chapter 17 Planning Future Clinical Trials for Machado-Joseph Disease
  19. Altmetric Badge
    Chapter 18 Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis
  20. Altmetric Badge
    Chapter 19 Pharmacological Therapies for Machado-Joseph Disease
  21. Altmetric Badge
    Chapter 20 Gene Therapies for Polyglutamine Diseases
  22. Altmetric Badge
    Chapter 21 Stem Cell-Based Therapies for Polyglutamine Diseases
Attention for Chapter 10: Spinocerebellar Ataxia Type 17 (SCA17)
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Spinocerebellar Ataxia Type 17 (SCA17)
Chapter number 10
Book title
Polyglutamine Disorders
Published in
Advances in experimental medicine and biology, January 2018
DOI 10.1007/978-3-319-71779-1_10
Pubmed ID
Book ISBNs
978-3-31-971778-4, 978-3-31-971779-1
Authors

Yasuko Toyoshima, Hitoshi Takahashi

Abstract

In 1999, a polyglutamine expansion was identified in the transcription factor TATA-binding protein (TBP) in a patient with ataxia with negative family history. Subsequently, CAG/CAA repeat expansions in the TBP gene were identified in families with spinocerebellar ataxia (SCA), establishing this repeat expansion as the underlying mutation in SCA type 17 (SCA17). There are several characteristic differences between SCA17 and other polyglutamine diseases. First, SCA17 shows a complex and variable clinical phenotype, in some cases overlapping that of Huntington's disease. Second, compared to the other SCA subtypes caused by expanded trinucleotide repeats, anticipation in SCA17 kindreds is rare because of the characteristic structure of the TBP gene. And thirdly, SCA17 patients often have diagnostic problems that may arise from non-penetrance. Because the gap between normal and abnormal repeat numbers is very narrow, it is difficult to determine a cutoff value for pathologic CAG repeat number in SCA17. Herein, we review the clinical, genetic and pathologic features of SCA17.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 22%
Researcher 4 13%
Student > Doctoral Student 3 9%
Student > Master 3 9%
Lecturer 2 6%
Other 4 13%
Unknown 9 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 25%
Neuroscience 7 22%
Medicine and Dentistry 5 16%
Nursing and Health Professions 1 3%
Veterinary Science and Veterinary Medicine 1 3%
Other 1 3%
Unknown 9 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2018.
All research outputs
#13,380,993
of 22,703,044 outputs
Outputs from Advances in experimental medicine and biology
#1,870
of 4,906 outputs
Outputs of similar age
#217,989
of 440,589 outputs
Outputs of similar age from Advances in experimental medicine and biology
#60
of 237 outputs
Altmetric has tracked 22,703,044 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,906 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,589 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 237 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.